Abingdon Health’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Abingdon Health develops, manufactures and commercializes immunoassay tests and reader systems. Read more

49 Followers on Owler
49 Followers on Owler
49 Followers on Owler
49 Followers on Owler

Abingdon Health develops, manufactures and commercializes immunoassay tests and reader systems. Read more

Chris Yates's photo - Co-Founder & CEO of Abingdon Health

Co-Founder & CEO

Chris Yates

CEO Approval Rating

83/100

Founded:

2008

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Atomo Diagnostics is perceived as one of Abingdon Health's biggest rivals. Atomo Diagnostics was founded in 2010, and its headquarters is in Leichhardt, New South Wales. Atomo Diagnostics competes in the Health Care Equipment field. Atomo Diagnostics has NaN fewer employees than Abingdon Health.

Sekisui is one of Abingdon Health's top rivals. Sekisui is a Private company that was founded in 2011 in Burlington, Massachusetts. Sekisui operates in the Health Care Equipment industry. Compared to Abingdon Health, Sekisui has 430 more employees.

BioFire Diagnostics, Inc. is Abingdon Health's #3 rival. BioFire Diagnostics, Inc. is a Private company that was founded in Salt Lake City, Utah in 1990. BioFire Diagnostics, Inc. is in the Biotechnology industry. BioFire Diagnostics, Inc. has 1,417 more employees vs. Abingdon Health.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $20M a good estimate for Abingdon Health's revenue?

Acquisitions

No recent acquisitions found related to Abingdon Health

Abingdon Health Funding History

$4.9M$8.3M$13M$17M$18.9M

Since Abingdon Health was founded in 2008, it has participated in 5 rounds of funding. In total Abingdon Health has raised $18.9M. Abingdon Health's last funding round was on Jan 2019 for a total of $2.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jan 2019
$2M

NPIF

Unattributed
Jul 2016
$3.9M
Equity
Jun 2015
$4.7M
Equity
Oct 2014
$3.4M
Equity
Mar 2012
$4.9M

Since Abingdon Health was founded in 2008, it has participated in 5 rounds of funding. In total Abingdon Health has raised $18.9M. Abingdon Health's last funding round was on Jan 2019 for a total of $2.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

LDL is a provider of molecular diagnostic tests for food producers, healthcare and defense sectors.
$2.6M
Nov 13, 2019
Equity
-

Abingdon Health News

November 17, 2020The Business Desk

Yorkshire developed Covid-19 test approved for use in North America | TheBusinessDesk.com

Same test has previously been given go ahead for professional use in the UK and EU... See more »
September 2, 2020MarketScreener

Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity

(marketscreener.com) Manufacturing agreement with Abingdon Health for Avacta's rapid COVID-19 saliva ... See more »
September 2, 2020Sharecast

Avacta signs Covid-19 test manufacturing deal with Abingdon

Biotherapeutics company Avacta Group has entered into an agreement with Abingdon Health for the manuf... See more »
July 7, 2020York Press

Abingdon Health leads UK antibody test team

A YORK diagnostics company has led a team to swiftly develop Covid-19 antibody tests which are now re... See more »
July 7, 2020Lab Bulletin

Abingdon Health announces its latest expansion and additional manufacturing capacity

Abingdon Health is pleased to announce further expansion at its York headquarters in the UK, followin... See more »
July 3, 2020The Business Desk

Yorkshire led consortium reaches milestone in antibody test | TheBusinessDesk.com

Milestone means a home test kit moves a step closer... See more »
June 17, 2020Medical Device News Magazine

Abingdon Health Announces Its Latest Expansion and Additional Manufacturing Capacity

This will provide a significant increase in its manufacturing footprint, resulting in Europe's larges... See more »

Abingdon Health Press Releases

July 16, 2015NEWSWISE

Commercial Launch of Rapid Diagnostic Device for Multiple Myeloma

Seralite(r) - FLC is a rapid diagnostic device for the quantitative measurement of kappa (K) and lamb... See more »

Abingdon Health Videos

Social Media

Headquarters

National Innovation Campus Sand Hutton

York, EnglandYO41 1LZ

44-1904-406-082

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Abingdon Health develops, manufactures and commercializes immunoassay tests and reader systems. Abingdon Health was founded in 2008. Abingdon Health's headquarters is located in York, England, GB YO41 1LZ. It has raised 18.9M in 5 rounds. The latest r...

CEO

Abingdon Health's Co-Founder & CEO, Chris Yates, currently has an approval rating of 83%. Abingdon Health's primary competitors are Atomo Diagnostics, Sekisui & BioFire Diagnostics, Inc..

Website

abingdonhealth.com

Frequently Asked Questions about Abingdon Health

  1. When was Abingdon Health founded?

    Abingdon Health was founded in 2008
  2. Who is Abingdon Health's CEO?

    Abingdon Health's CEO is Chris Yates
  3. How much revenue does Abingdon Health generate?

    Abingdon Health generates $20M in revenue
  4. How much funding does Abingdon Health have?

    Abingdon Health has historically raised $18.9M in funding
  5. Where is Abingdon Health's headquarters?

    Abingdon Health's headquarters is in York England, GB
  1. How many employees does Abingdon Health have?

    Abingdon Health has 20 employees
  2. What sector does Abingdon Health operate in?

    Abingdon Health is in Health Care Technology
  3. Who are Abingdon Health's competitors?

    Abingdon Health's top competitors are Atomo Diagnostics, Sekisui, BioFire Diagnostics, Inc.
  4. Who has Abingdon Health invested in?

    Abingdon Health's has invested in companies such as Linear Diagnostics